What Is the Culture of S. Cerevisiae for Vitamins?

Culturing Saccharomyces cerevisiae for vitamins involves growing this common yeast under controlled conditions that either coax it to produce vitamins it already knows how to make or, increasingly, engineering it to synthesize vitamins it normally cannot. The reference strain S288C already carries the genes needed to build most of the B-group vitamins found in standard lab media, which means the culture strategy often revolves around fermentation conditions, carbon sources, and post-harvest processing rather than the organism’s raw capability.¹ But the story gets more interesting when researchers push yeast beyond its native repertoire, using genetic engineering to produce compounds like β-carotene, vitamin A, and even vitamin D2 at commercially relevant scales.

Which Vitamins Can S. Cerevisiae Make on Its Own

S. cerevisiae is sometimes described as vitamin-dependent because lab media recipes include B vitamins. That framing is misleading. The yeast genome actually encodes the machinery for synthesizing most of those same vitamins. The term “vitamin” in yeast biology is borrowed from human nutrition, where it refers to compounds we must get from food. The yeast itself can build many of them from scratch.¹ Among the compounds the standard reference strain can produce are thiamine (B1), riboflavin (B2), pyridoxine (B6), folate (B9), pantothenic acid (B5), nicotinic acid (B3), and biotin (B7), though the completeness of each pathway varies across wild and industrial strains. When vitamins are added to lab media, it is mostly a convenience to ensure robust growth rather than a reflection of true auxotrophy.

This native vitamin toolkit has practical implications. If the goal is to harvest B vitamins from yeast biomass, much of the work centers on choosing the right strain, tuning the growth environment, and deciding how to break open the cells afterward. If the goal is a vitamin that yeast cannot naturally make, the challenge shifts to metabolic engineering.

Thiamine Biosynthesis and Its Regulation

Thiamine production inside S. cerevisiae is tightly controlled. The yeast synthesizes thiamine (vitamin B1) through a dedicated set of genes, and intracellular levels are linked to the cell’s broader metabolic state. One regulatory layer involves the cell’s own supply of NAD+, a coenzyme central to energy metabolism. When NAD+ levels drop and a specific enzyme complex is inhibited, the yeast ramps up both thiamine synthesis and thiamine transport, effectively boosting its internal B1 stores.² This means researchers can, in principle, manipulate thiamine output by altering the yeast’s NAD+ balance.

There is also a more direct genetic approach. Two regulatory genes, THI2 and THI3, act as switches for the thiamine pathway. When researchers disrupted these genes in an industrial strain, the mutants shifted their metabolism in ways that redirected carbon flow, boosting pyruvate production at the expense of thiamine synthesis.³ This finding cuts both ways: it shows that thiamine biosynthesis is tunable through genetic intervention, and it illustrates how yeast vitamin production is intertwined with other metabolic goals. Depending on what you want the fermentation to produce, you might turn the thiamine pathway up or down.

Folate Production and the Carbon Source Question

Folate (vitamin B9) synthesis in S. cerevisiae proceeds through a multi-step pathway that converts a simple sugar phosphate intermediate into the pteridine ring structure at folate’s core. Two enzymes handle the critical step of attaching glutamate tails to the folate molecule: one adds the first glutamate, the other extends the chain. Without a functional copy of the gene for the first enzyme (FOL3), the yeast cannot make folate at all and needs it supplied externally. The longer glutamate tails, added by a second enzyme encoded by MET7, are essential for methionine synthesis and for keeping mitochondrial DNA intact.⁴

A more recent and striking finding concerns what the yeast eats. Most fermentation runs use glucose as the carbon source, and folate production from glucose is well established. But researchers have now shown that S. cerevisiae can also synthesize folate when grown on acetate as its sole carbon source, achieving concentrations around 3.3 mg per 100 g of biomass. About 90% of the total folate consisted of two biologically active forms. This matters because acetate can be made from CO2 and renewable electricity, opening a route to vitamin production that does not depend on agricultural sugars at all.⁵

Pyridoxine and Other B Vitamin Pathways

Vitamin B6 (pyridoxine) synthesis in S. cerevisiae relies on two genes, SNO1 and SNZ1, that are counterparts of pyridoxine-synthesis genes found in other fungi.⁶ These gene products work together to produce the vitamin’s precursor, and their activity can vary between strains. Beyond B6, S. cerevisiae also makes riboflavin (B2), nicotinic acid (B3), pantothenic acid (B5), and biotin (B7) through their respective biosynthetic routes, though individual lab and industrial strains sometimes carry mutations that cripple one pathway or another. The practical takeaway: when culturing yeast specifically for B vitamin content, strain selection matters as much as the growth medium.

The Ergosterol-to-Vitamin D2 Route

Yeast does not produce vitamin D2 during normal growth, but it makes a precursor that sits one step away. Ergosterol is the primary sterol in the yeast cell membrane, playing a structural role analogous to cholesterol in human cells. When yeast biomass is exposed to ultraviolet light, ergosterol undergoes a photochemical conversion into vitamin D2.⁷ The conversion is not especially efficient under brief exposure: about 15 minutes of UV-C irradiation yields a conversion rate of roughly 1.8%.⁸ That sounds modest, but because yeast biomass is cheap and ergosterol concentrations in yeast are naturally high, the process is commercially viable for producing vitamin D2 supplements, especially for vegan markets that avoid animal-derived vitamin D3.

Researchers are also working to boost ergosterol levels within the yeast itself through genetic engineering of the sterol biosynthesis pathway, which would raise the ceiling for how much vitamin D2 each batch of irradiated yeast can deliver.⁷

Engineering Yeast for Vitamins It Cannot Naturally Make

Some of the most active research involves turning S. cerevisiae into a factory for vitamins entirely outside its normal metabolic reach. Three examples stand out: β-carotene (a provitamin A carotenoid), retinol (vitamin A itself), and vitamin B12.

For β-carotene, researchers have inserted carotenoid biosynthesis genes from other organisms into yeast. One approach borrowed genes from a red yeast (Sporidiobolus pararoseus) and combined them with boosted flux through the native mevalonate pathway to push carbon toward carotenoid production.⁹ Another team introduced carotenogenic genes from Xanthophyllomyces dendrorhous into a xylose-fermenting yeast and found that the resulting strain produced β-carotene from xylose at a level threefold higher than from glucose.¹⁰ The carbon source, in other words, is not a minor detail. It can dramatically shift yields.

Going a step further, researchers have converted β-carotene into retinol (vitamin A) inside the yeast cell by adding an enzyme that cleaves the carotenoid molecule. One group identified two such enzymes with different cleavage mechanisms and combined them in a single strain to increase the conversion rate.¹¹ In a separate effort, a multidimensional engineering strategy that included diverting carbon away from squalene (a competing product) pushed retinol titers up to 1.41 g/L in fermentation broth.¹² That figure is high enough to attract commercial attention.

Vitamin B12 is a different kind of challenge. S. cerevisiae does not naturally need or produce B12. But its status as a well-understood organism with mature genetic tools makes it an appealing host for heterologous B12 production. Researchers have begun engineering B12 dependency into yeast as a stepping stone toward building a full production pathway.¹³ That work is still at an early stage compared to the β-carotene and retinol platforms, but it illustrates the ambition driving the field.

Fermentation Conditions That Shape Vitamin Output

Culture parameters like pH, temperature, and aeration rate all affect how much vitamin yeast cells accumulate. One detailed study on β-carotene production in a recombinant wine yeast found that a two-stage pH strategy outperformed any constant pH setting. The approach held pH at 7.0 for the first 24 hours to promote growth, then shifted it to 5.0 to induce a mild oxidative stress that stimulated carotenoid accumulation. The result was a peak β-carotene concentration of about 50 mg/L, roughly a 19% improvement over the best constant-pH run.¹⁴ Adding an antioxidant reversed the improvement, confirming that the oxidative stress itself was driving higher production. The lesson here applies broadly: fine-tuning environmental stresses during fermentation can coax yeast into making more of a target compound.

Carbon source is another lever. Glucose is the default, but as noted with folate and β-carotene, switching to acetate or xylose can alter yields substantially. Choosing the right feedstock depends on cost, availability, and how it interacts with the specific biosynthetic pathway you are trying to exploit.

Getting Vitamins Out of the Cell

Vitamins produced inside yeast cells are trapped behind the cell wall, which means downstream processing is just as important as the fermentation itself. The three main industrial approaches for breaking open yeast cells are mechanical disruption (using a bead mill or ultrasound), autolysis (letting the yeast’s own enzymes digest the cell wall at elevated temperature), and chemical or enzymatic lysis.

Comparing these head-to-head, mechanical methods preserved more of the B vitamins in the resulting yeast extract. The biologically active form of folate, 5-methyltetrahydrofolate, made up a larger proportion of the total folate in mechanically produced extracts than in autolysates.¹⁵ The likely explanation is that autolysis involves prolonged heat exposure, which degrades some heat-sensitive vitamins. Protein content and fat recovery were also higher in mechanically produced extracts.

Enzymatic hydrolysis using a protease offers a middle ground. It releases more total protein and soluble solids than either autolysis or simple chemical lysis, and the resulting product retains useful biological activity including antioxidant properties.¹⁶ For a manufacturer optimizing specifically for vitamin yield, mechanical disruption currently looks best; for broader nutritional extract applications, enzymatic hydrolysis may be more practical.

Live Yeast, Dead Yeast, and the Bioavailability Problem

This is an underappreciated wrinkle in the story of yeast-derived vitamins. Not all yeast biomass delivers its vitamins equally, and the critical variable is whether the cells are alive or dead at the time of consumption.

Classic human feeding studies found that thiamine in fresh, living baker’s yeast was essentially unavailable for absorption. Worse, eating live yeast actually interfered with the absorption of thiamine from other foods in the diet, apparently because the living cells competed with the human gut for available B1. The effect was dose-dependent and progressive: larger doses and longer periods of live yeast ingestion depleted the subjects’ thiamine stores further. However, yeast that had been killed by commercial drying or boiling released its thiamine for absorption normally and did not interfere with dietary thiamine uptake.¹⁷

The implication for anyone producing or consuming yeast-based vitamin supplements is straightforward: the yeast needs to be dead. Live dried yeast suitable for baking behaved the same as fresh yeast in withholding its thiamine. Only heat-killed or commercially dried yeast reliably delivered vitamins to the consumer. This finding shapes how supplement manufacturers process their products and partly explains why “nutritional yeast” on store shelves is always an inactivated product.

Encapsulation and Food Fortification

Beyond harvesting vitamins from yeast cells, researchers are also using intact yeast cells as delivery vehicles. The rigid cell wall of S. cerevisiae turns out to be an effective microcapsule for protecting vitamins during food processing. In one study, vitamin D3 was loaded into yeast cells and then used to fortify bread. The yeast-cell capsules shielded more than 95% of the vitamin D3 from degradation during baking at 180°C for 30 minutes. Bread made with encapsulated vitamin D3 also scored higher in sensory evaluations than bread fortified with the free vitamin.¹⁸ This dual-use concept, where yeast contributes both its own endogenous B vitamins and serves as a protective shell for added vitamins, is gaining traction in functional food development.

Regulatory Considerations for Engineered Strains

When the yeast strain producing vitamins has been genetically modified, regulatory frameworks come into play. Agencies in the United States, European Union, and Canada all evaluate the safety of genetically engineered microorganisms used in food production, reviewing both the organism itself and the resulting food substance.¹⁹ For vitamins produced by engineered S. cerevisiae, this typically involves demonstrating that the final product is free of the modified organism (or that any residual organism is safe) and that the vitamin itself is chemically identical to its conventionally produced counterpart. The regulatory path adds time and cost but has not prevented commercialization of other yeast-derived ingredients, and the general trajectory is toward broader acceptance of fermentation-derived vitamins.

Scaling Up and the Sustainability Angle

A growing body of work is exploring whether yeast-based vitamin production can scale up enough to matter for global nutrition while also shrinking the environmental footprint. One detailed techno-economic assessment modeled a system at industrial scale (1,750 cubic meters) that feeds S. cerevisiae with acetate made from CO2 and renewable electricity. The system was projected to yield about 813 kg of folate and 5,600 tonnes of protein per year from roughly 31,300 tonnes of CO2 input. At a daily serving of just 6 grams of dried yeast product per person, the output could meet the full recommended daily allowance for folate and about 5% of the protein RDA for 5.6 million people, with a payback period of around five years at a product price of $20 per kilogram.²⁰

These numbers are modeled rather than demonstrated at full scale, and the economics depend heavily on the cost of renewable electricity and the market price of folate. Still, the concept of producing vitamins from CO2 rather than agricultural feedstocks is appealing for regions where arable land is scarce or where supply chains for conventional vitamin ingredients are unreliable. S. cerevisiae is already one of the most thoroughly understood and industrially domesticated organisms on the planet, which gives it a head start over less-established microbial platforms for any scaled process.²¹

Strain Variation Across the Saccharomyces Genus

One complication that rarely makes it into popular accounts is that “S. cerevisiae” is not a single, uniform thing. Industrial brewing strains, laboratory reference strains, wild isolates, and bakery strains can differ substantially in which vitamin pathways are fully functional. A comparative genomics analysis across the Saccharomyces genus found meaningful diversity in vitamin prototrophy, meaning some species and strains have intact pathways for a given vitamin while close relatives do not.¹ For anyone setting up a vitamin-production process, this means strain screening is not optional. Picking a strain based on convenience or availability, rather than verifying its biosynthetic completeness for the target vitamin, is a common early mistake in both academic and industrial labs. The reference strain S288C is well characterized, but it was selected for genetic tractability, not for vitamin output, and industrial strains optimized for ethanol tolerance or growth rate may have drifted in their vitamin-synthesis capabilities over generations of selective pressure toward other traits.

1
PubMed Central. Vitamin requirements and biosynthesis in Saccharomyces cerevisiae
2
PubMed Central. Thiamine Biosynthesis in Saccharomyces cerevisiae Is Regulated by the NAD+-Dependent Histone Deacetylase Hst1
3
PubMed. Regulation of thiamine synthesis in Saccharomyces cerevisiae for improved pyruvate production
4
PubMed. Polyglutamylation of folate coenzymes is necessary for methionine biosynthesis and maintenance of intact mitochondrial genome in Saccharomyces cerevisiae
5
Trends in Biotechnology. Power-to-vitamin: coupling microbial acetate production with yeast folate bio-synthesis
6
PubMed. Characterization of the products of the genes SNO1 and SNZ1 involved in pyridoxine synthesis in Saccharomyces cerevisiae
7
PubMed. Reengineering of ergosterol biosynthesis in Saccharomyces cerevisiae and its sustainable application in citrus peel processing industry
8
PubMed Central. Quantitative Analysis of Vitamin D2 and Ergosterol in Yeast-Based Supplements Using High-Performance Liquid Chromatography with Ultraviolet Detection
9
PubMed Central. Sustainable β-carotene production by engineered S. cerevisiae using sucrose and agricultural by-products
10
PubMed. High-level β-carotene production from xylose by engineered Saccharomyces cerevisiae without overexpression of a truncated HMG1 (tHMG1)
11
Synthetic and Systems Biotechnology. Systematic metabolic engineering enables highly efficient production of vitamin A in Saccharomyces cerevisiae
12
PubMed. Multidimensional Engineering of Saccharomyces cerevisiae for Efficient Production of Retinol
13
PubMed. Development of vitamin B12 dependency in Saccharomyces cerevisiae
14
Process Biochemistry. A pH control strategy for increased β-carotene production during batch fermentation by recombinant industrial wine yeast
15
European Food Research and Technology. Yeast extract production using spent yeast from beer manufacture: influence of industrially applicable disruption methods on selected substance groups with biotechnological relevance
16
PubMed. Autolysis, plasmolysis and enzymatic hydrolysis of baker’s yeast (Saccharomyces cerevisiae): a comparative study
17
The Journal of Nutrition. The Availability of Vitamins from Yeasts. IV. The Influence of the Ingestion of Fresh and Dried Bakers’ Yeasts, Variously Killed, on the Availability of Thiamine for Humans
18
Human, Health and Halal Metrics. Study of UV and thermal stability of Vitamin D3 loaded in yeast cells of Saccharomyces cerevisiae microcapsules
19
PubMed. GEMs: genetically engineered microorganisms and the regulatory oversight of their uses in modern food production
20
Proceedings of the National Academy of Sciences. Power-to-Vitamins or Power-to-Protein: An evaluation of the integrated system at an industrial scale from techno-economic perspectives
21
PubMed Central. Microbial Cell Factories for Green Production of Vitamins